PTPI Projected Dividend Yield
Petros Pharmaceuticals Inc ( NASDAQ : PTPI )Petros Pharmaceuticals is a pharmaceutical company focused on men's health therapeutics with a range of capabilities including sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. Co. is engaged in the commercialization and development of Stendra®, a PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). Co. also markets its own line of ED products in the form of vacuum erection device products. In addition to ED products, Co. has a license to develop and commercialize H100™, a topical formulation candidate for the treatment of acute Peyronie's disease. 20 YEAR PERFORMANCE RESULTS |
PTPI Dividend History Detail PTPI Dividend News PTPI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |